What Does an Abnormal Breast Ultrasound Look Like?

An abnormal breast ultrasound shows one or more features that stand out from the surrounding tissue and raise concern: an irregularly shaped mass, a solid lump with jagged edges, a fluid-filled sac with thick internal walls, shadowing behind a hard lesion, or increased blood flow feeding into a suspicious area. None of these findings automatically means cancer, but each one changes what happens next. The specific combination of features on the screen is what guides a radiologist toward reassurance, short-term follow-up, or biopsy.

How Radiologists Categorize What They See

When a radiologist reads your breast ultrasound, they assign a BI-RADS category, a standardized scoring system that translates the visual findings into a recommendation. Category 1 is normal. Category 2 is benign, meaning something is there but it is clearly harmless. Category 3 means “probably benign,” and the usual recommendation is a short-interval follow-up scan in six months. Category 4 means suspicious, and biopsy is typically recommended. Category 5 is highly suggestive of malignancy, and biopsy is essentially mandatory.¹

The jump from one category to another depends on specific visual characteristics: the shape, margins, orientation, internal echo pattern, and presence of features like calcifications or shadowing. A mass that is oval, smooth-edged, and lying parallel to the chest wall looks very different from one that is taller than it is wide, spiculated, and casting a dark shadow behind it. The first pattern is reassuring; the second raises red flags.

What Cysts Look Like and When They Become Concerning

Cysts are among the most common findings on breast ultrasound, and most are entirely benign. A simple cyst appears as a round or oval dark area with sharp, smooth borders and a bright band of signal behind it called posterior enhancement. That bright band occurs because sound waves travel easily through fluid. Simple cysts are classified as BI-RADS 2 and need no further workup.²

Complicated cysts look almost the same but contain internal debris, so the inside is not perfectly black. They meet all other criteria for a simple cyst except that clear, echo-free interior. These are generally classified as BI-RADS 3 and watched with a follow-up scan. Clustered microcysts, which appear as a group of tiny dark spaces bunched together without any solid tissue between them, are considered BI-RADS 2.²

The category that warrants the most attention is the complex cystic and solid mass. These contain both fluid and solid components. You might see thick walls, thick internal dividers, or a solid nodule growing inside or along the wall of a cyst. They are typically classified as BI-RADS 4 and come with a biopsy recommendation.² The key distinction is that complicated cysts just have murky fluid mimicking solid tissue, while complex cystic masses genuinely contain solid material alongside the fluid.³

Benign Solid Masses and Their Typical Appearance

Fibroadenomas are the most familiar benign solid breast lump, especially in younger people. On ultrasound, a classic fibroadenoma shows up as an oval or round mass lying parallel to the chest wall, with smooth edges, a uniform internal texture, and no dark shadowing behind it.⁴ The margins are well-defined, meaning you can see exactly where the lump ends and the normal tissue begins. In one study evaluating fibroadenoma features, about 58% had circumscribed margins, though roughly a fifth had edges that were not as clearly defined.⁵

That last detail matters because it means not every fibroadenoma looks textbook-perfect. Some have slightly irregular borders or mixed internal echoes, which can push them into higher BI-RADS categories and prompt a biopsy even though the lump turns out to be harmless. This is one reason biopsy rates are higher than cancer rates: the imaging is designed to err on the side of caution.

Features That Raise Suspicion for Cancer

Cancerous masses tend to share a cluster of visual features. The shape is often irregular rather than oval or round. The margins may be jagged, spiculated (with spike-like projections), or indistinct, blending into the surrounding tissue. Malignant masses frequently stand taller than they are wide when viewed head-on, meaning they grow against the natural tissue planes rather than along them.

Posterior acoustic shadowing, a dark zone behind the mass, is another common sign. Research comparing benign and malignant masses with this type of shadowing found that the two groups differed significantly in size, margin clarity, internal echo pattern, the presence of calcifications, and blood flow characteristics.⁶ Shadowing alone is not diagnostic, since dense benign tissue can cast shadows too, but shadowing behind a mass with other worrisome features adds weight to the concern.

Blood flow is another piece of the puzzle. Cancers tend to recruit new blood vessels to fuel their growth, and Doppler ultrasound can pick up this increased vascularity. In one study, blood vessels were detected in about 97% of malignant lesions compared to 35% of benign ones.⁷ Still, blood flow alone cannot make the call. Some cancers are avascular, and some benign tumors have abundant blood supply.⁸ The pattern of vascularity, combined with the other features, is what matters.

Calcifications on Ultrasound

Tiny calcium deposits, called microcalcifications, are a hallmark finding on mammography but are harder to spot on ultrasound. Standard grayscale ultrasound picks up only a fraction of the microcalcifications that mammography reveals. Newer processing modes like MicroPure imaging can detect significantly more: in one study, readers identified an average of about 14 microcalcifications with MicroPure versus only 3 with conventional ultrasound on the same specimens.⁹

When ultrasound does show calcifications, they appear as tiny bright specks, sometimes with faint shadowing behind them. The clinical value is that when calcifications are visible on ultrasound alongside a mass, the likelihood of malignancy goes up. One study found that ultrasound detected associated masses in 82% of malignant microcalcification clusters versus only 23% of benign ones.¹⁰ Lesions visible on ultrasound were also more likely to be malignant (69%) than those ultrasound could not detect (21%), and the visible malignant lesions were more likely to be invasive cancers.¹¹

Non-Mass Abnormalities

Not every abnormality on breast ultrasound shows up as a defined lump. Some appear as areas where the tissue texture looks different from the surrounding breast without forming a discrete, three-dimensional mass. These are called non-mass lesions, and they are the ultrasound equivalent of subtle asymmetries seen on mammography.¹²

These areas of altered echogenicity lack clear borders and do not bulge or displace the surrounding tissue the way a mass does. They can, however, include calcifications, architectural distortion (where normal tissue planes are pulled or disrupted), or shadowing. Non-mass lesions span a wide range of diagnoses, from entirely benign conditions to cancer.¹³ Because they are harder to characterize than a well-defined lump, they often require additional imaging or biopsy to sort out.

Abnormal Lymph Nodes

If a breast mass raises concern, the radiologist will often scan the armpit on the same side. Normal lymph nodes have a thin outer layer and a bright fatty center. When cancer spreads to a lymph node, one of the earliest changes is thickening of the outer cortex, which can progress to complete loss of the bright fatty hilum in the center.¹⁴

Research has found that a cortical thickness greater than 5 mm and loss of the normal fatty hilum are the features most strongly associated with malignancy in axillary lymph nodes.¹⁵ Increasing cortical thickness, abnormal hilum, and diffuse cortical thickening all independently raise the likelihood of nodal metastasis in newly diagnosed breast cancer patients.¹⁶ When a node looks suspicious, the radiologist can perform an ultrasound-guided biopsy of the node itself, which may change surgical planning.

What Inflammation Looks Like

Breast infections and inflammatory conditions produce their own set of ultrasound findings. Infectious mastitis typically shows up as diffuse skin thickening, tissue swelling, and fluid collections (abscesses). Non-infectious inflammation, on the other hand, more often presents as one or more solid-looking masses.¹⁷ This distinction is clinically relevant because a mass caused by a condition like granulomatous mastitis can closely mimic cancer on imaging, sometimes requiring biopsy to tell them apart.¹⁸

If you are being scanned because of breast redness, swelling, or pain, these inflammatory findings are important context. The sonographer and radiologist will factor in your symptoms, whether you are breastfeeding, and how quickly the problem developed when deciding whether an area of abnormal tissue needs a biopsy or a course of antibiotics and a follow-up scan.

Elastography and Tissue Stiffness

Some ultrasound machines can measure how stiff a breast mass is, using a technique called elastography. Cancerous tissue tends to be stiffer than benign tissue because of the dense, fibrous scaffolding that tumors build around themselves. Elastography provides a color-coded map or a numerical stiffness value that supplements the standard grayscale image.

Adding elastography to conventional ultrasound significantly improves the ability to tell benign from malignant masses. One study reported that standard ultrasound alone achieved an accuracy (measured by area under the curve) of about 0.85, while adding either shear-wave or strain elastography raised it to roughly 0.96.¹⁹ Research comparing the two main types of elastography found that malignant lesions had mean elasticity ratios several times higher than benign ones.²⁰ Shear-wave elastography has been suggested as a way to improve the specificity of conventional ultrasound, potentially reducing unnecessary biopsies for masses that look ambiguous on standard imaging but turn out to be soft.²¹

Dense Breasts and Why Ultrasound Finds What Mammography Misses

If you have dense breast tissue, mammography becomes less reliable because both dense tissue and masses appear white on the image, making small tumors easy to overlook. Ultrasound helps by using a different technology altogether: sound waves rather than X-rays. A meta-analysis found that mammography alone had a pooled sensitivity of about 74% for cancer detection in women with dense breasts, while combining mammography with ultrasound raised sensitivity to about 96%.²²

The trade-off is specificity. Adding ultrasound also increases the chance of finding things that look abnormal but turn out to be benign. Another meta-analysis, looking at women with dense breasts and negative mammograms, documented hundreds of additional cancers caught by supplemental screening methods across a large pooled population.²³ For people with dense tissue, an “abnormal” ultrasound may be the first sign that something mammography could not see needs a closer look.

What Happens After an Abnormal Finding

An abnormal ultrasound finding almost always leads to one of three paths: short-interval follow-up (usually in six months), ultrasound-guided biopsy, or additional imaging such as MRI. Ultrasound-guided biopsy has become the primary method for sampling suspicious breast findings, with diagnostic accuracy approaching that of open surgical biopsy.²⁴

After biopsy, the radiologist compares the pathology results to the imaging appearance to check for concordance. If the biopsy says “benign” but the mass looked highly suspicious on imaging, that mismatch (discordance) may prompt repeat biopsy or surgical excision. In one audit, about 92% of results were concordant, meaning the pathology matched the imaging impression. Roughly 8% were discordant, meaning imaging and pathology told different stories and additional steps were needed.²⁵

Breast Implants on Ultrasound

If you have silicone breast implants, ultrasound plays a specific role in checking for rupture. A normal implant shows a smooth shell and uniform fill. When an implant ruptures but the silicone stays inside the fibrous capsule your body has formed around it (intracapsular rupture), ultrasound may reveal telltale signs: a “stepladder” pattern of collapsed shell fragments floating inside the implant, a “keyhole” or “noose” shape at the fold lines, or a line of silicone creeping between the shell layers. If silicone has leaked outside the capsule entirely (extracapsular rupture), it creates a distinctive “snowstorm” appearance of bright, noisy echoes in the surrounding tissue.²⁶

Ultrasound in Men and in Younger Patients

Male breast ultrasound is less common, but when it happens the findings can be confusing. Gynecomastia (benign enlargement of breast tissue in men) and male breast cancer both tend to occur in the area just behind the nipple. Male breast cancer accounts for up to 1% of all breast cancer cases, and it often looks similar to female breast cancer on ultrasound: an irregular mass that may have associated calcifications. Occasionally, though, male breast cancer can appear oval with smooth margins, mimicking a benign finding, which is why most solid breast masses in men still require tissue sampling.²⁷

In children and adolescents, the picture shifts dramatically. Breast masses in this age group are uncommon and overwhelmingly benign. Ultrasound is the go-to imaging tool because there is no radiation exposure and the developing breast tissue is well-suited to sound-wave imaging. When malignancy does occur in pediatric patients, it is more often a metastasis from another cancer than a primary breast tumor.²⁸ Findings in a teenager’s breast scan should always be interpreted in light of age: the same mass that would be biopsied in a 55-year-old might simply be monitored in a 16-year-old.

Post-Treatment Changes That Mimic Abnormalities

If you have had breast surgery, radiation therapy, or both, follow-up ultrasounds can be tricky to read. Scar tissue, fat necrosis (where fatty tissue dies and forms a firm lump), and radiation-related skin thickening can all produce ultrasound appearances that overlap with the secondary signs of cancer.²⁹ Radiologists reading post-treatment scans rely heavily on comparison with prior imaging and knowledge of exactly where surgery was performed. If you have had breast-conserving surgery, make sure your imaging team has access to your surgical and radiation records. Without that context, a scar can easily be flagged as suspicious.

Artificial Intelligence and Automated Ultrasound

AI tools are being developed to assist radiologists in reading breast ultrasound images, and some are already performing at expert levels. One deep learning system achieved roughly 91% accuracy in categorizing automated breast ultrasound images into BI-RADS categories, with agreement comparable to experienced human readers.³⁰ Another model achieved a cancer detection rate of about 90% on an external validation set, matching the performance of seasoned sonologists.³¹

These systems are not replacing radiologists, but they are increasingly used as a second set of eyes, flagging suspicious areas that a busy reader might overlook or helping to standardize interpretations across different clinics. The technology still faces challenges with variability across different ultrasound machines and patient populations, and real-world clinical validation is ongoing.³² For now, the practical takeaway is that if your imaging center uses AI-assisted reading, it may contribute to a more thorough evaluation of your scan.